FDA and EMA activity last week (08 to 14 January 2024): drug approvals, positive opinions, safety surveillance and alerts
European Medicine Agency (EMA) The next CHPM meeting is planned on the of week of 22 Jan 2024.If you are interested about the summary of previous CHMP meetings, send an email to [email protected] with in the title: CHMP, we will take care of it. US Food and Drug Administration (FDA) No new drugs were approved […]
Drug news 08 January 2024: New data, approvals, safety alerts
Happy New Year! 2023 ended with major events: 1st Crisper therapy approved by regulators: MHRA 1st, FDA and EMA. Several transactions with significant valuations (e.g. Karuna $14.0 B, Cerevel $8.7 Bn). Let’s see what 2024 will bring to all of us! European Medicine Agency (EMA) The next CHPM meeting is planned on the of week of 22 […]